Patents
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
12/2004
12/21/2004US6833387 Chemical compounds
12/21/2004US6833384 Deacetylase inhibitors
12/21/2004US6833378 Pyridines, pyrimidines, purinones, pyrrolopyrimidinones and pyrrolopyridinones; useful in the treatment disorders including CNS and stress-related disorders.
12/21/2004US6833372 A hormone inhibitors of gonadotropin releasing hormone, an antigonadotropins, new drug compound contains a furanyl 2-carboxylic acid -(2,4-dimethoxy-pyrimidin-5-yl)-amide groups
12/16/2004WO2004108711A1 Pyrazinil quinazoline derivatives for use in the treatment of tumours
12/16/2004WO2004108710A1 4-pyrimidinyl quinazoline derivatives for use in the treatment of tumours
12/16/2004WO2004108709A1 Tetrazol benzofurancarboxamides with p13k aktivity as therapeutic agents
12/16/2004WO2004108688A1 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
12/16/2004WO2004108684A1 Novel azole derivative having antifungal activity
12/16/2004WO2004108672A1 Isoindolin-1-one compounds as kinase inhibitors
12/16/2004WO2004108134A1 Medicinal composition containing triazole compound
12/16/2004WO2004108133A2 Modulators of vr1 receptor
12/16/2004WO2004108085A2 Methods for the protection of memory and cognition
12/16/2004WO2004087686A3 Benzopyran compounds useful for treating inflammatory conditions
12/16/2004WO2004087677A3 Pyrimidin-4-one derivatives and their use as p38 kinase modulators
12/16/2004WO2004080411A3 Melanin-concentrating hormone receptor antagonists and compositions and methods related thereto
12/16/2004WO2004078030B1 Rhodol derivatives useful as image dyes
12/16/2004WO2003105538A8 Electroluminescent device
12/16/2004US20040254376 Cyclic amidine derivative
12/16/2004US20040254374 Alanyl-piperidine heterocyclic derivatives useful against cardiovascular diseases
12/16/2004US20040254233 Pyrazolidinone compounds as ligands of the prostaglandin ep2 and/or ep4 receptors
12/16/2004US20040254213 Use of bicyclo compounds for treating alzheimer's disease
12/16/2004US20040254203 Methods and compositions utilizing quinazolinones
12/16/2004US20040254201 Substituted-1,3-oxathiolanes and substituted-1,3-dioxolanes with antiviral properties
12/16/2004US20040254187 5-ethyl-imidazotriazinones
12/16/2004US20040254186 Pyridylfurans and pyrroles as raf kinase inhibitors
12/16/2004US20040254185 Endothelial growth factor antagonist; angiogenesis inhibitor; skin disorders; anticancer agents; endometriosis; Crohn's disease; leukemia; antiarthritic agents; vision defects
12/16/2004US20040254184 Psychological disorders; antidepressants; anxiolytic agents; analgesics; antiinflammatory agents; central nervous system disorders
12/16/2004US20040254179 Central nervous system disorders; psycholgical disorders; antiepi;eptic agents; schizophrenia; Alzheimer's disease; cognition activators; analgesics
12/16/2004US20040254177 Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them
12/16/2004US20040254167 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
12/16/2004US20040254159 Antiproliferative agents
12/16/2004US20040254141 Therapy for hepatitis B virus infection ; antiproliferative agents; antitumor agents; anticancer agents
12/16/2004CA2528924A1 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
12/16/2004CA2527934A1 Tetrazol benzofurancarboxamides with p13k activity as therapeutic agents
12/16/2004CA2527814A1 Isoindolin-1-one compounds as kinase inhibitors
12/16/2004CA2527114A1 Methods for the protection of memory and cognition
12/15/2004EP1486549A1 Organic electroluminescent element
12/15/2004EP1486489A2 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
12/15/2004EP1486207A2 Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same
12/15/2004EP1485387A1 Carbamates as hiv protease inhibitors
12/15/2004EP1485375A1 Pyrimidine compounds
12/15/2004EP1485371A2 Indole amide derivatives and their use as glycogen phosphorylase inhibitors
12/15/2004EP1485370A1 Amino-derivatives as novel inhibitors of histone deacetylase
12/15/2004EP1485365A1 Sulfonyl-derivatives as novel inhibitors of histone deacetylase
12/15/2004EP1485364A1 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
12/15/2004EP1485360A2 Sodium channel blockers
12/15/2004EP1485358A1 Broadspectrum substituted benzimidazole sulfonamide hiv protease inhibitors
12/15/2004EP1485356A1 NON-PEPTIDE GnRH ANTAGONISTS
12/15/2004EP1485354A1 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
12/15/2004EP1485353A1 New inhibitors of histone deacetylase
12/15/2004EP1485351A2 Process for the manufacture of optically active 3-substituted lactams by asymmetric hydrogenation of 3-alkylidenelactams
12/15/2004EP1485167A1 1,2-dihydropyrazol-3-ones as cytokine mediators
12/15/2004EP1485100A1 Azinylaminoazoles as inhibitors of protein kinases
12/15/2004EP1485099A1 Inhibitors of histone deacetylase
12/15/2004EP1485093A1 Di-aryl substituted tetrazole modulators of metabotropic glutamate receptor-5
12/15/2004EP1485089A1 Combination treatments for chemokine-mediated diseases
12/15/2004EP1484971A1 4-aminopyrimidines and their use for the antimicrobial treatment of surfaces
12/15/2004EP1337520B1 Substituted 5-aryl and 5-heteroaryl-2-(2-hydroxyphenyl)-2h-benzotriazole derivatives as uv absorbers
12/15/2004EP1307447B1 3-indolyl-4-phenyl-1h-pyrrole-2,5-dione derivatives as inhibitors of glycogen synthase kinase-3beta
12/15/2004EP1284267B1 Triazole compounds having amide linkage
12/15/2004EP1278742B1 Chromenylmethylpyrimidinediamines as antibacterial agents
12/15/2004EP1091957B1 Pyrimidin-aminomethyl-pyridine derivatives, their preparation and their use in the control of helicobacter bacteria
12/15/2004EP1047415B1 Pig appeasing pheromones to decrease stress, anxiety and aggressiveness
12/15/2004EP0788507B1 L-pyranosyl nucleosides
12/15/2004CN1555260A Aminoalkyl-substituted aromatic bicyclic compounds, methods for their preparation and their use as pharmaceuticals
12/15/2004CN1179954C Substd. heterocyclic compounds, preparing process thereof and pharmaceutical composition contg. them
12/15/2004CN1179948C HIV protease inhibitors
12/15/2004CN1179945C Indole derivatives, process for preparation of same and use thereof
12/15/2004CN1179944C 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses
12/14/2004US6831199 Pyrimidine compounds and derivatives thereof
12/14/2004US6831177 Preparation of their intermediates, 2-acyl-5-benzylfuran derivatives and 1,2,4-triazole-3- carboxylic acid ester derivatives
12/14/2004US6831174 Processes for preparing substituted 1, 3-oxathiolanes with antiviral properties
12/14/2004US6831096 Effective against both A and B forms of influenza; oral bioavailability
12/14/2004US6831085 Methods and compositions utilizing quinazolinones
12/14/2004US6831075 Heterocyclic substituted pyrazolones
12/14/2004CA2225453C Compounds with chelation affinity and selectivity for first transition series elements, and their use in medical therapy and diagnosis
12/09/2004WO2004106330A1 Benzopyran derivatives substituted with a benzimidazole derivative, pharmaceutically acceptable salts thereof, their preparations and pharmaceutical compositions containing them
12/09/2004WO2004106329A2 Novel antiinfective compounds and their pharmaceutical compositions
12/09/2004WO2004106328A1 Triheterocyclic compounds, compositions, and methods for treating cancer or viral diseases
12/09/2004WO2004106317A1 Benzofuran compound and medicinal composition containing the same
12/09/2004WO2004106315A2 4-amino-2(5h)-furanones useful as cholecystokinin antagonists
12/09/2004WO2004106308A1 Quinazolines and pyrido [3,4-d] pyrimidines as receptor tyrosine kinase inhibitors
12/09/2004WO2004106307A2 Novel imidazole derivatives, the production thereof, and the use of the same as a medicament
12/09/2004WO2004106304A2 3 - [2- (3-amino-2-oxo-2h-pyridin-1-yl) - acetylamino] - 4- oxo-pentanoic acid derivatives and their use as caspase inhibitors
12/09/2004WO2004106302A1 Novel substituted 3-sulfur indoles
12/09/2004WO2004106299A2 Substituted pyrrole derivatives and their use as hmg-co inhibitors
12/09/2004WO2004106296A2 Trisubstituted heteroaromatic compounds as calcium sensing receptor modulators
12/09/2004WO2004105753A1 Antidepressant or food or beverage for antidepression
12/09/2004WO2004105752A1 Substituted pyrrole derivatives as hmg-coa reductase inhibitors
12/09/2004WO2004105488A1 Hydrazone derivatives for combatting harmful insects and arachnids
12/09/2004WO2004094388A3 Indazole derivatives as jnk inhibitors
12/09/2004WO2004089901A3 Phospholipase c inhibitors for use in treating inflammatory disorders
12/09/2004WO2004089892A3 Diarylmethyl and related compounds having beta2 andrenergic receptor agonist and muscarinic receptor antagonist activity
12/09/2004WO2004072041A8 Tetrahydroquinolines as agonists of liver- x receptors
12/09/2004WO2003080582A3 Fredericamycin derivatives
12/09/2004US20040249168 Useful pharmaceutical intermediates which can be used in the preparation of the hydroxymethyl-glutaryl coenzyme (HMG-COA) reducing enzyme inhibitor having the INN (International Non-proprietory Name) atorvastatin
12/09/2004US20040249154 Process for the manufacture of organic compounds
12/09/2004US20040249147 Reacting an epoxy alcohol with reactants having active hydrogen attached to nitrogen, oxygen or sulfur in the presence of redox coupling agents comprising a reducing agent and an oxidizing agent for producing azole compound
12/09/2004US20040248958 Heterocyclic amide derivatives